SCHEMBL4104419

SCHEMBL4104419

CCCC(=O)c1ccc(F)c2c(F)cccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 5/20 0.43
HSD17B10 Q99714 4/20 0.43
POLB P06746 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 2/20 0.43
GLA P06280 1/20 0.43
MAPT P10636 3/20 0.40
F2R P25116 1/20 0.40
TDP1 Q9NUW8 3/20 0.40
LMNA P02545 3/20 0.40
ALOX15 P16050 2/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.40
GMNN O75496 2/20 0.40
MAPK1 P28482 2/20 0.40
BLM P54132 2/20 0.40
PMP22 Q01453 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4104386 0.88 HSP90AB1 (0.40) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL4116766 0.83 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL6744512 0.78 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL11836782 0.77 CES2 (0.57) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL3121320 0.77 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL7307327 0.77 HPGD (0.43) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL1260174 0.76 ALB (0.56) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL13263817 0.76 ESR1 (0.46) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL27170475 0.75 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL4108916 0.75 CNR1 (0.36) ALDH1A1KDM4EHPGDF2RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221645-A1 Dihydroimidazothiazole Derivatives TPH1, HTR3B, HTR1A ALDH1A1 195/4885KDM4E 2133/4885HPGD 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.